Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating CPAP treatment for severe asthma patients with sleep apnea

Official title: Effect of CPAP Treatment on Asthma Control in Patients With Severe Uncontrolled Asthma and Obstructive Sleep Apnea: The ASTHMA-SLEEP Study

Run by Hospital Clinic of Barcelona · NCT06314477 · Data updated 2026-11-12

This study is testing if using a CPAP machine can help adults with severe asthma and sleep apnea breathe better and manage their asthma more effectively.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment138 (estimated)
SponsorHospital Clinic of Barcelona
Academic / other
Locations1 site (Barcelona, Spain)
StatusRecruiting
StartedFebruary 29, 2024
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedSeptember 21, 2026
Trial IDNCT06314477 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with severe uncontrolled asthma and an apnea-hypopnea index of 15 or higher.

Probably not a fit

Patients with central sleep apnea, other significant sleep disorders, or unstable comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effects of Continuous Positive Airway Pressure (CPAP) treatment on asthma control in patients suffering from severe uncontrolled asthma and obstructive sleep apnea (OSA). It is a multicenter, prospective, randomized, controlled clinical trial involving adults over 18 years old who meet specific criteria for asthma severity and sleepiness levels. Participants will undergo polysomnography to confirm OSA and will be randomized to receive either standard treatment or standard treatment plus CPAP for a duration of 12 months, with evaluations at multiple time points.

Why it matters

Potential benefit: If successful, this study could significantly improve asthma control in patients with severe uncontrolled asthma and OSA.

How similar studies have gone: Previous observational studies have shown promise for CPAP treatment in patients with mild to moderate asthma, but this approach in severe uncontrolled asthma is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18 years
* Diagnosis of severe uncontrolled asthma according to the criteria of the Spanish Asthma Management Guide (GEMA) or the Global Initiative for Asthma (GINA) and no hospitalizations the month prior to inclusion in the study.
* Apnea hypopnea rate greater than or equal to 15/hour
* Punctuation in the Epworth Sleepiness Scale ≤10
* Obtaining informed consent.

Exclusion Criteria:

* Previous treatment with CPAP
* Patient with central sleep apnea or Cheyne-Stokes respiration
* Other sleep disorders: narcolepsy, restless leg syndrome, chronic insomnia,
* Resistant hypertension
* Active Smoking
* Unstable comorbidities or medications may interfere with asthma control
* Pregnancy
* Any process that reduces life expectancy to \<1 year,
* Any medical or social factor that may limit CPAP compliance

Where it's running

  • Hospital Clinic Barcelona
    Barcelona, Spain, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.